Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Gotlandsbolaget in connection with ship sales
Mandate

Vinge advises Gotlandsbolaget in connection with ship sales

November 30, 2022 Maritime and Transport Law M&A

Gotlandsbolaget and its subsidiary Gotland Tankers have implemented four successful sales of the tankers M/T Gotland Carolina, M/T Gotland Sofia, M/T Gotland Aliya andM/T Gotland Marieann respectively.

The ships are built between 2006 and 2008 in the Gotland Class series. Vinge has advised Gotlandsbolaget throughout the transaction and provided advice in conjunction with contract negotiations, delivery of the ships as well as deregistration from the Bahamian shipping register.

Vinge’s team consisted of Paula Bäckdén and Hanna Marberg supported by  Amelia Rihs  as well as Petronella Hallberg regarding company law issues. The sales mean that all ships of the Gotland Class series have been sold and, according to Gotlandsbolaget, this is part of the company’s strategy to focus even more on industrial shipping and infrastructure.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025